- Supports medical device manufacturing in Asia with additional ethylene oxide processing capacity
- Complements existing radiation and gas processing facilities in China, Malaysia, and Thailand
July 9th, 2024 – As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce a new ethylene oxide (EO) processing facility in Singapore through a strategic partnership with TOMOE SHOKAI CO., Ltd (“TOMOE”). The addition of the EO facility to the STERIS network complements our existing electron beam, gamma, X-ray, and microbiological testing services in Kuala Ketil, Kulim, Port Klang, and Rawang, Malaysia; Chonburi, Thailand; and Suzhou, China.
Additional EO processing capacity in Asia furthers our commitment to ensuring patient safety through a technology-neutral service offering that includes radiation and gas processing options, now and well into the future.
Our global EO offering includes Sustainable EO® sterilization services, which provides Customers with strategies to reduce the EO sterilant used in the sterilization process to achieve the prescribed Sterility Assurance Level. The program includes innovative approaches to EO sterilization, such as cycle design, validation strategy, and process challenge device design, all focused on reducing EO residuals on healthcare products.
The addition of EO capacity in Singapore allows for increased technology-neutral processing options in the APAC region and throughout our global network, and allows us to support Customers with both routine services and processing redundancy.
About STERIS
STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life sciences products and services. For more information, visit www.steris.com.
###
